Logo image of WLGS

WANG & LEE GROUP INC (WLGS) Stock Fundamental Analysis

NASDAQ:WLGS - Nasdaq - VGG9T22C1003 - Common Stock - Currency: USD

0.0684  -0.01 (-9.04%)

After market: 0.0635 0 (-7.16%)

Fundamental Rating

1

Taking everything into account, WLGS scores 1 out of 10 in our fundamental rating. WLGS was compared to 51 industry peers in the Construction & Engineering industry. WLGS may be in some trouble as it scores bad on both profitability and health. WLGS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year WLGS has reported negative net income.
WLGS had a negative operating cash flow in the past year.
WLGS Yearly Net Income VS EBIT VS OCF VS FCFWLGS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 200K -200K -400K -600K

1.2 Ratios

Looking at the Return On Assets, with a value of -27.06%, WLGS is doing worse than 86.54% of the companies in the same industry.
Industry RankSector Rank
ROA -27.06%
ROE N/A
ROIC N/A
ROA(3y)-6.94%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
WLGS Yearly ROA, ROE, ROICWLGS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 100 200

1.3 Margins

The Gross Margin of WLGS (21.47%) is better than 69.23% of its industry peers.
The Profit Margin and Operating Margin are not available for WLGS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
WLGS Yearly Profit, Operating, Gross MarginsWLGS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 10 -10 20 30

More info and screens

0

2. Health

2.1 Basic Checks

WLGS does not have a ROIC to compare to the WACC, probably because it is not profitable.
WLGS has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, WLGS has an improved debt to assets ratio.
WLGS Yearly Shares OutstandingWLGS Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 5M 10M 15M
WLGS Yearly Total Debt VS Total AssetsWLGS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of -0.51, we must say that WLGS is in the distress zone and has some risk of bankruptcy.
WLGS's Altman-Z score of -0.51 is on the low side compared to the rest of the industry. WLGS is outperformed by 90.38% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.51
ROIC/WACCN/A
WACC8.86%
WLGS Yearly LT Debt VS Equity VS FCFWLGS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 2M 4M

2.3 Liquidity

A Current Ratio of 0.69 indicates that WLGS may have some problems paying its short term obligations.
WLGS has a Current ratio of 0.69. This is amonst the worse of the industry: WLGS underperforms 84.62% of its industry peers.
A Quick Ratio of 0.69 indicates that WLGS may have some problems paying its short term obligations.
WLGS has a worse Quick ratio (0.69) than 84.62% of its industry peers.
Industry RankSector Rank
Current Ratio 0.69
Quick Ratio 0.69
WLGS Yearly Current Assets VS Current LiabilitesWLGS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for WLGS have decreased strongly by -235.76% in the last year.
The Revenue has been growing slightly by 4.12% in the past year.
Measured over the past years, WLGS shows a quite strong growth in Revenue. The Revenue has been growing by 18.77% on average per year.
EPS 1Y (TTM)-235.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-432.67%
Revenue 1Y (TTM)4.12%
Revenue growth 3Y18.77%
Revenue growth 5YN/A
Sales Q2Q%14.96%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
WLGS Yearly Revenue VS EstimatesWLGS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2M 4M 6M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for WLGS. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WLGS Price Earnings VS Forward Price EarningsWLGS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WLGS Per share dataWLGS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

WLGS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

WANG & LEE GROUP INC

NASDAQ:WLGS (6/13/2025, 8:00:02 PM)

After market: 0.0635 0 (-7.16%)

0.0684

-0.01 (-9.04%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)04-18 2025-04-18
Earnings (Next)N/A N/A
Inst Owners10.84%
Inst Owner ChangeN/A
Ins Owners0.71%
Ins Owner ChangeN/A
Market Cap1.45M
AnalystsN/A
Price TargetN/A
Short Float %29.61%
Short Ratio0.19
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.27
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.15
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.26
BVpS-0.08
TBVpS-0.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.06%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.47%
FCFM N/A
ROA(3y)-6.94%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.75
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.69
Quick Ratio 0.69
Altman-Z -0.51
F-Score4
WACC8.86%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-235.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-432.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.12%
Revenue growth 3Y18.77%
Revenue growth 5YN/A
Sales Q2Q%14.96%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-77.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y26.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y26.93%
OCF growth 3YN/A
OCF growth 5YN/A